Table of Contents
1 Table Of Contents 2
1.1 List of Tables 10
1.2 List of Figures 13
2 Introduction 15
2.1 What Is This Report About? 15
3 Definitions of
the Markets Covered in the Report 16
3.1 Ophthalmic Devices 16
3.2
Cataract Surgery 16
3.2.1 Phacoemulsification Equipment 16
3.2.2 Intra
Ocular Lens 16
3.3 Vision Care 16
3.3.1 Ophthalmoscopes 16
3.3.2
Contact lenses 16
3.3.3 Lens care 16
3.3.4 Ophthalmic lens 17
3.3.5 Rigid Gas Permeable Contact Lenses 17
3.4 Refractive Surgery 17
4 Ophthalmic Devices in North America 18
4.1 Ophthalmic Devices Cross
Country Comparison (2000-2012) 18
4.2 Ophthalmic Devices, North America,
Overall Revenues ($ mn), 2000-2012 19
4.3 Ophthalmic Devices, North
America, Company Share (2006-2007) 23
5 Ophthalmic Devices In United
States 24
5.1 Ophthalmic Devices, United States, Overall Revenues ($ mn),
2000-2012 24
5.2 Ophthalmic Devices, United States, Category Volume
(Units), 2000-2012 27
5.3 Ophthalmic Devices, United States, Distribution
Share (2006-2007) 28
5.3.1 Cataract Surgery Distribution Share (2006-2007)
28
5.3.2 Refractive Surgery Distribution Share (2006-2007) 28
5.3.3
Vision Care Distribution Share (2006-2007) 29
5.4 Ophthalmic Devices,
United States, Company Share (2006-2007) 30
5.4.1 Ophthalmic Devices,
United States, Company Share (2006-2007) 30
5.4.2 Cataract Surgery, United
States, Company Share (2006-2007) 31
5.4.3 Refractive Surgery, United
States, Company Share (2006-2007) 32
5.4.4 Vision Care, United States,
Company Share (2006-2007) 33
6 Ophthalmic Devices In Canada 34
6.1
Ophthalmic Devices, Canada, Overall Revenues ($ mn), 2000-2012 34
6.2
Ophthalmic Devices, Canada, Category Volume (Units), 2000-2012 37
6.3
Ophthalmic Devices, Canada, Distribution Share (2006-2007) 38
6.3.1
Cataract Surgery Distribution Share (2006-2007) 38
6.3.2 Refractive
Surgery Distribution Share (2006-2007) 38
6.3.3 Vision Care Distribution
Share (2006-2007) 39
6.4 Ophthalmic Devices, Canada Company Share
(2006-2007) 40
6.4.1 Ophthalmic Devices, Canada Company Share (2006-2007)
40
6.4.2 Cataract Surgery, Canada, Company Share (2006-2007) 41
6.4.3
Refractive Surgery, Canada, Company Share (2006-2007) 42
6.4.4 Vision
Care, Canada, Company Share (2006-2007) 43
7 Johnson & Johnson Vision
Care, Inc. Company Profile 44
7.1 Company Overview 44
8 Essilor
International Company Profile 45
8.1 Company Overview 45
8.2 Value
Chain Analysis 45
8.2.1 Manufacturing 45
8.2.2 Product Development
46
8.2.3 Sales and Marketing 46
9 Bausch & Lomb Incorporated Company
Profile 47
9.1 Company Overview 47
9.2 Value Chain Analysis 47
9.2.1 Manufacturing 47
9.2.2 Product Development 48
9.2.3 Sales and
Marketing 49
9.3 Bausch & Lomb Incorporated Pipeline Products 49
9.3.1
Bausch & Lomb Incorporated Pipeline Products by Equipment Type 49
9.3.2
Bausch & Lomb Incorporated Pipeline Products by Development Stage 50
9.3.3
Bausch & Lomb Incorporated Pipeline Products by Therapy Area 50
9.3.4
Bausch & Lomb Incorporated Pipeline Products by Clinical Trials 50
9.3.5
Bausch & Lomb Incorporated Pipeline Products by News Summary 50
10 CIBA
Vision Corporation Company Profile 51
10.1 Company Overview 51
10.2
CIBA Vision Corporation Pipeline Products 51
10.2.1 CIBA Vision
Corporation Pipeline Products by Equipment Type 51
10.2.2 CIBA Vision
Corporation Pipeline Products by Development Stage 51
10.2.3 CIBA Vision
Corporation Pipeline Products by Therapy Area 51
10.2.4 CIBA Vision
Corporation Pipeline Products by Clinical Trials 51
11 Alcon, Inc. Company
Profile 52
11.1 Company Overview 52
11.2 Value Chain Analysis 52
11.2.1 Manufacturing 53
11.2.2 Product Development 53
11.2.3 Sales and
Marketing 54
11.3 Alcon, Inc. Pipeline Products 55
11.3.1 Alcon, Inc.
Pipeline Products by Equipment Type 55
11.3.2 Alcon, Inc. Pipeline
Products by Development Stage 55
11.3.3 Alcon, Inc. Pipeline Products by
Therapy Area 55
11.3.4 Alcon, Inc. Pipeline Products by Clinical Trials
56
11.3.5 Alcon, Inc. Pipeline Products by News Summary 56
12 SEIKO
OPTICAL PRODUCTS CO., LTD. Company Profile 57
12.1 Company Overview 57
13 Advanced Medical Optics, Inc. Company Profile 58
13.1 Company Overview
58
13.2 Value Chain Analysis 58
13.2.1 Manufacturing 58
13.2.2
Product Development 59
13.2.3 Sales and Marketing 59
13.3 Advanced
Medical Optics, Inc. Pipeline Products 60
13.3.1 Advanced Medical Optics,
Inc. Pipeline Products by Equipment Type 60
13.3.2 Advanced Medical
Optics, Inc. Pipeline Products by Development Stage 60
13.3.3 Advanced
Medical Optics, Inc. Pipeline Products by Therapy Area 60
13.3.4 Advanced
Medical Optics, Inc. Pipeline Products by Clinical Trials 60
14 Carl Zeiss
AG Company Profile 61
14.1 Company Overview 61
14.2 Value Chain
Analysis 61
14.2.1 Manufacturing 61
14.2.2 Product Development 62
14.2.3 Sales and Marketing 62
15 CooperVision, Inc. Company Profile 64
15.1 Company Overview 64
15.2 Cooper Vision, Inc. Pipeline Products 64
15.2.1 Cooper Vision, Inc. Pipeline Products by Equipment Type 64
15.2.2
Cooper Vision, Inc. Pipeline Products by Development Stage 64
15.2.3
Cooper Vision, Inc. Pipeline Products by Therapy Area 65
16 Calhoun
Vision, Inc. Company Profile 66
16.1 Company Overview 66
16.2 Calhoun
Vision, Inc. Pipeline Products 66
16.2.1 Calhoun Vision, Inc. Pipeline
Products by Equipment Type 66
16.2.2 Calhoun Vision, Inc. Pipeline
Products by Development Stage 66
16.2.3 Calhoun Vision, Inc. Pipeline
Products by Therapy Area 66
16.2.4 Calhoun Vision, Inc. Pipeline Products
by News Summary 66
17 Labtician Ophthalmics, Inc. Company Profile 67
17.1 Company Overview 67
18 Lenstec, Inc. Company Profile 68
18.1
Company Overview 68
18.2 Lenstec, Inc. Pipeline Products 68
18.2.1
Lenstec, Inc. Pipeline Products by Equipment Type 68
18.2.2 Lenstec, Inc.
Pipeline Products by Development Stage 68
18.2.3 Lenstec, Inc. Pipeline
Products by Therapy Area 69
18.2.4 Lenstec, Inc. Pipeline Products by
Clinical Trials 69
18.2.5 Lenstec, Inc. Pipeline Products by News Summary
69
19 Lux Biosciences, Inc. Company Profile 70
19.1 Company Overview
70
19.2 Lux Biosciences, Inc. Pipeline Products 70
19.2.1 Lux
Biosciences, Inc. Pipeline Products by Equipment Type 70
19.2.2 Lux
Biosciences, Inc. Pipeline Products by Development Stage 70
19.2.3 Lux
Biosciences, Inc. Pipeline Products by Therapy Area 70
19.2.4 Lux
Biosciences, Inc. Pipeline Products by Clinical Trials 71
20 Medennium
Inc. Company Profile 72
20.1 Company Overview 72
20.2 Medennium Inc.
Pipeline Products 72
20.2.1 Medennium Inc. Pipeline Products by Equipment
Type 72
20.2.2 Medennium Inc. Pipeline Products by Development Stage
72
20.2.3 Medennium Inc. Pipeline Products by Therapy Area 72
21
NeoMedix Inc. Company Profile 73
21.1 Company Overview 73
21.2
NeoMedix Inc. Pipeline Products 73
21.2.1 NeoMedix Inc. Pipeline Products
by Equipment Type 73
21.2.2 NeoMedix Inc. Pipeline Products by Development
Stage 73
21.2.3 NeoMedix Inc. Pipeline Products by Therapy Area 73
21.2.4 NeoMedix Inc. Pipeline Products by Clinical Trials 73
21.2.5
NeoMedix Inc. Pipeline Products by News Summary 74
22 NeoVista, Inc.
Company Profile 75
22.1 Company Overview 75
22.2 NeoVista, Inc.
Pipeline Products 75
22.2.1 NeoVista, Inc. Pipeline Products by Equipment
Type 75
22.2.2 NeoVista, Inc. Pipeline Products by Development Stage
75
22.2.3 NeoVista, Inc. Pipeline Products by Therapy Area 75
22.2.4
NeoVista, Inc. Pipeline Products by Clinical Trials 75
22.2.5 NeoVista,
Inc. Pipeline Products by News Summary 76
23 OccuLogix, Inc. Company
Profile 77
23.1 Company Overview 77
23.2 OccuLogix, Inc. Pipeline
Products 77
23.2.1 OccuLogix, Inc. Pipeline Products by Equipment Type
77
23.2.2 OccuLogix, Inc. Pipeline Products by Development Stage 77
23.2.3 OccuLogix, Inc. Pipeline Products by Therapy Area 78
23.2.4
OccuLogix, Inc. Pipeline Products by Clinical Trials 78
23.2.5 OccuLogix,
Inc. Pipeline Products by News Summary 78
24 Ophthalmic Technologies Inc.
Company Profile 79
24.1 Company Overview 79
24.2 Ophthalmic
Technologies Inc. Pipeline Products 79
24.2.1 Ophthalmic Technologies Inc.
Pipeline Products by Equipment Type 79
24.2.2 Ophthalmic Technologies Inc.
Pipeline Products by Development Stage 79
24.2.3 Ophthalmic Technologies
Inc. Pipeline Products by Therapy Area 79
25 Second Sight Company Profile
80
25.1 Company Overview 80
25.2 Second Sight Pipeline Products 80
25.2.1 Second Sight Pipeline Products by Equipment Type 80
25.2.2 Second
Sight Pipeline Products by Development Stage 80
25.2.3 Second Sight
Pipeline Products by Therapy Area 80
25.2.4 Second Sight Pipeline Products
by Clinical Trials 81
25.2.5 Second Sight Pipeline Products by News
Summary 81
26 STAAR Surgical Company Company Profile 82
26.1 Company
Overview 82
26.2 STAAR Surgical Company Pipeline Products 82
26.2.1
STAAR Surgical Company Pipeline Products by Equipment Type 82
26.2.2 STAAR
Surgical Company Pipeline Products by Development Stage 82
26.2.3 STAAR
Surgical Company Pipeline Products by Therapy Area 83
26.2.4 STAAR
Surgical Company Pipeline Products by Clinical Trials 83
26.2.5 STAAR
Surgical Company Pipeline Products by News Summary 83
27 TEKIA, INC.
Company Profile 84
27.1 Company Overview 84
27.2 TEKIA, INC. Pipeline
Products 84
27.2.1 TEKIA, INC. Pipeline Products by Equipment Type 84
27.2.2 TEKIA, INC. Pipeline Products by Development Stage 84
27.2.3 TEKIA,
INC. Pipeline Products by Therapy Area 85
27.2.4 TEKIA, INC. Pipeline
Products by Clinical Trials 85
27.2.5 TEKIA, INC. Pipeline Products by
News Summary 85
28 VisionCare Ophthalmic Technologies, Inc. Company
Profile 86
28.1 Company Overview 86
28.2 VisionCare Ophthalmic
Technologies, Inc. Pipeline Products 86
28.2.1 VisionCare Ophthalmic
Technologies, Inc. Pipeline Products by Equipment Type 86
28.2.2
VisionCare Ophthalmic Technologies, Inc. Pipeline Products by Development
Stage 86
28.2.3 VisionCare Ophthalmic Technologies, Inc. Pipeline Products
by Therapy Area 86
28.2.4 VisionCare Ophthalmic Technologies, Inc.
Pipeline Products by Clinical Trials 87
28.2.5 VisionCare Ophthalmic
Technologies, Inc. Pipeline Products by News Summary 87
29 Visual
Pathways, Inc. Company Profile 88
29.1 Company Overview 88
29.2 Visual
Pathways, Inc. Pipeline Products 88
29.2.1 Visual Pathways, Inc. Pipeline
Products by Equipment Type 88
29.2.2 Visual Pathways, Inc. Pipeline
Products by Development Stage 88
29.2.3 Visual Pathways, Inc. Pipeline
Products by Therapy Area 89
29.2.4 Visual Pathways, Inc. Pipeline Products
by Clinical Trials 89
29.2.5 Visual Pathways, Inc. Pipeline Products by
News Summary 89
30 Financial Deals Landscape 90
30.1 Acquisition
90
30.2 Partnerships 94
31 Recent Developments 95
31.1 Product
News 95
31.1.1 Dec 23, 2008: Alcon Announces FDA Approval For Its AcrySof
IQ ReSTOR +3.0 D Intraocular Lens 95
31.1.2 Nov 08, 2008: BD Launches BD
Atomic Edge Safety LRI Knives 95
31.1.3 Nov 05, 2008: Unilens Launches New
C-VUE Advanced Custom Toric Lens 96
31.1.4 Oct 23, 2008: Bausch & Lomb
Highlights SofLens Daily Disposable Contact Lenses At American Academy Of
Optometry Annual Meeting 96
31.1.5 Oct 07, 2008: Advanced Medical Optics
Receives FDA Approval For Healon D Viscoelastic For Ophthalmic Surgery 97
31.1.6 Sep 15, 2008: FDA Approves Bausch & Lomb Akreos Advanced Optics
Aspheric Lens 97
31.1.7 Aug 26, 2008: Interventional Ophthalmology
Procedure Indicated For Treatment Of Glaucoma 97
31.1.8 Aug 15, 2008:
IRIDEX Announces FDA Clearance For New 577 nm True-Yellow Laser 97
31.1.9
Aug 07, 2008: STAAR Surgical' s VISIAN ICL To Be Featured On CBS Early Show
98
32 APPENDIX 99
32.1 Global Markets Direct Research Methodology
99
32.2 Coverage 100
32.3 Secondary Research 100
32.4 Primary
Research 101
32.5 Models 101
32.6 Forecasts 102
32.7 Expert Panels
102
32.8 Currency Conversion 103
32.9 Contact Us 104
32.10
Disclaimer 104
1.1 List of Tables
Table 1: Ophthalmic
Devices, North America, Cross Country Comparison, Revenues ($ mn), 2000-2012
17
Table 2: Ophthalmic Devices, North America, Overall Revenues ($
mn), 2000-2012 18
Table 3: Ophthalmic Devices, North America, Overall
Revenues ($ mn), 2000-2012 19
Table 4: Ophthalmic Devices, North
America, Overall Revenues ($ mn), Historic, 2000-2007 20
Table 5:
Ophthalmic Devices, North America, Overall Revenues ($ mn), Forecast,
2007-2012 21
Table 6: Ophthalmic Devices, North America, Company
Share by Revenue ($ mn), 2006-2007 22
Table 7: Ophthalmic Devices,
United States, Overall Revenues ($ mn), 2000-2012 23
Table 8:
Ophthalmic Devices, United States, Overall Revenues ($ mn), Historic,
2000-2007 24
Table 9: Ophthalmic Devices, United States, Overall
Revenues ($ mn), Forecast, 2007-2012 25
Table 10: Ophthalmic Devices,
United States, Category Volume (Units), 2000-2012 26
Table 11:
Ophthalmic Devices, United States, Category Volume (Units), Historic,
2000-2007 26
Table 12: Ophthalmic Devices, United States, Category
Volume (Units), Forecast, 2007-2012 26
Table 13: Cataract Surgery,
United States, Distribution Share by Revenue ($mn), 2006-2007 27
Table 14:
Refractive Surgery, United States, Distribution Share by Revenue ($mn),
2006-2007 27
Table 15: Vision Care, United States, Distribution Share
by Revenue ($mn), 2006-2007 28
Table 16: Ophthalmic Devices, United
States, Company Share by Revenue ($ mn), 2006-2007 29
Table 17:
Cataract Surgery, United States, Company Share by Revenue ($ mn), 2006-2007
30
Table 18: Refractive Surgery, United States, Company Share by
Revenue ($ mn), 2006-2007 31
Table 19: Vision Care, United States,
Company Share by Revenue ($ mn), 2006-2007 32
Table 20: Ophthalmic
Devices, Canada, Overall Revenues ($ mn), 2000-2012 33
Table 21:
Ophthalmic Devices, Canada, Overall Revenues ($ mn), Historic, 2000-2007
34
Table 22: Ophthalmic Devices, Canada, Overall Revenues ($ mn),
Forecast, 2007-2012 35
Table 23: Ophthalmic Devices, Canada, Category
Volume (Units), 2000-2012 36
Table 24: Ophthalmic Devices, Canada,
Category Volume (Units), Historic, 2000-2007 36
Table 25: Ophthalmic
Devices, Canada, Category Volume (Units), Forecast, 2007-2012 36
Table 26:
Cataract Surgery, Canada, Distribution Share by Revenue ($mn), 2006-2007
37
Table 27: Refractive Surgery, Canada, Distribution Share by
Revenue ($mn), 2006-2007 37
Table 28: Vision Care, Canada,
Distribution Share by Revenue ($mn), 2006-2007 38
Table 29:
Ophthalmic Devices, Canada Company Share by Revenue ($ mn), 2006-2007 39
Table 30: Cataract Surgery, Canada, Company Share by Revenue ($ mn),
2006-2007 40
Table 31: Refractive Surgery, Canada, Company Share by
Revenue ($ mn), 2006-2007 41
Table 32: Vision Care, Canada, Company
Share by Revenue ($ mn), 2006-2007 42
Table 33: Bausch & Lomb
Incorporated Pipeline Products by Equipment Type 48
Table 34: Bausch
& Lomb Incorporated Pipeline Products by Development Stage 49
Table 35:
Bausch & Lomb Incorporated Pipeline Products by Therapy Area 49
Table
36: Bausch & Lomb Incorporated Pipeline Products by Clinical Trials
49
Table 37: Bausch & Lomb Incorporated Pipeline Products by News
Summaries 49
Table 38: CIBA Vision Corporation Pipeline Products by
Equipment Type 50
Table 39: CIBA Vision Corporation Pipeline Products
by Development Stage 50
Table 40: CIBA Vision Corporation Pipeline
Products by Therapy Area 50
Table 41: CIBA Vision Corporation
Pipeline Products by Clinical Trials 50
Table 42: Alcon, Inc.
Pipeline Products by Equipment Type 54
Table 43: Alcon, Inc. Pipeline
Products by Development Stage 54
Table 44: Alcon, Inc. Pipeline
Products by Therapy Area 54
Table 45: Alcon, Inc. Pipeline Products
by Clinical Trials 55
Table 46: Alcon, Inc. Pipeline Products by News
Summaries 55
Table 47: Advanced Medical Optics, Inc. Pipeline
Products by Equipment Type 59
Table 48: Advanced Medical Optics, Inc.
Pipeline Products by Development Stage 59
Table 49: Advanced Medical
Optics, Inc. Pipeline Products by Therapy Area 59
Table 50: Advanced
Medical Optics, Inc. Pipeline Products by Clinical Trials 59
Table 51:
Cooper Vision, Inc. Pipeline Products by Equipment Type 63
Table 52:
Cooper Vision, Inc. Pipeline Products by Development Stage 63
Table 53:
Cooper Vision, Inc. Pipeline Products by Therapy Area 64
Table 54:
Calhoun Vision, Inc. Pipeline Products by Equipment Type 65
Table 55:
Calhoun Vision, Inc. Pipeline Products by Development Stage 65
Table 56:
Calhoun Vision, Inc. Pipeline Products by Therapy Area 65
Table 57:
Calhoun Vision, Inc. Pipeline Products by News Summaries 65
Table 58:
Lenstec, Inc. Pipeline Products by Equipment Type 67
Table 59:
Lenstec, Inc. Pipeline Products by Development Stage 67
Table 60:
Lenstec, Inc. Pipeline Products by Therapy Area 68
Table 61: Lenstec,
Inc. Pipeline Products by Clinical Trials 68
Table 62: Lenstec, Inc.
Pipeline Products by News Summaries 68
Table 63: Lux Biosciences,
Inc. Pipeline Products by Equipment Type 69
Table 64: Lux
Biosciences, Inc. Pipeline Products by Development Stage 69
Table 65:
Lux Biosciences, Inc. Pipeline Products by Therapy Area 69
Table 66:
Lux Biosciences, Inc. Pipeline Products by Clinical Trials 70
Table 67:
Medennium Inc. Pipeline Products by Equipment Type 71
Table 68:
Medennium Inc. Pipeline Products by Development Stage 71
Table 69:
Medennium Inc. Pipeline Products by Therapy Area 71
Table 70:
NeoMedix Inc. Pipeline Products by Equipment Type 72
Table 71:
NeoMedix Inc. Pipeline Products by Development Stage 72
Table 72:
NeoMedix Inc. Pipeline Products by Therapy Area 72
Table 73: NeoMedix
Inc. Pipeline Products by Clinical Trials 72
Table 74: NeoMedix Inc.
Pipeline Products by News Summaries 73
Table 75: NeoVista, Inc.
Pipeline Products by Equipment Type 74
Table 76: NeoVista, Inc.
Pipeline Products by Development Stage 74
Table 77: NeoVista, Inc.
Pipeline Products by Therapy Area 74
Table 78: NeoVista, Inc.
Pipeline Products by Clinical Trials 74
Table 79: NeoVista, Inc.
Pipeline Products by News Summaries 75
Table 80: OccuLogix, Inc.
Pipeline Products by Equipment Type 76
Table 81: OccuLogix, Inc.
Pipeline Products by Development Stage 76
Table 82: OccuLogix, Inc.
Pipeline Products by Therapy Area 77
Table 83: OccuLogix, Inc.
Pipeline Products by Clinical Trials 77
Table 84: OccuLogix, Inc.
Pipeline Products by News Summaries 77
Table 85: Ophthalmic
Technologies Inc. Pipeline Products by Equipment Type 78
Table 86:
Ophthalmic Technologies Inc. Pipeline Products by Development Stage 78
Table 87: Ophthalmic Technologies Inc. Pipeline Products by Therapy Area
78
Table 88: Second Sight Pipeline Products by Equipment Type 79
Table 89: Second Sight Pipeline Products by Development Stage 79
Table 90: Second Sight Pipeline Products by Therapy Area 79
Table 91:
Second Sight Pipeline Products by Clinical Trials 80
Table 92:
Second Sight Pipeline Products by News Summaries 80
Table 93: STAAR
Surgical Company Pipeline Products by Equipment Type 81
Table 94:
STAAR Surgical Company Pipeline Products by Development Stage 81
Table 95:
STAAR Surgical Company Pipeline Products by Therapy Area 82
Table 96:
STAAR Surgical Company Pipeline Products by Clinical Trials 82
Table
97: STAAR Surgical Company Pipeline Products by News Summaries 82
Table 98: TEKIA, INC. Pipeline Products by Equipment Type 83
Table
99: TEKIA, INC. Pipeline Products by Development Stage 83
Table 100:
TEKIA, INC. Pipeline Products by Therapy Area 84
Table 101:
TEKIA, INC. Pipeline Products by Clinical Trials 84
Table 102: TEKIA,
INC. Pipeline Products by News Summaries 84
Table 103: VisionCare
Ophthalmic Technologies, Inc. Pipeline Products by Equipment Type 85
Table
104: VisionCare Ophthalmic Technologies, Inc. Pipeline Products by
Development Stage 85
Table 105: VisionCare Ophthalmic Technologies,
Inc. Pipeline Products by Therapy Area 85
Table 106: VisionCare
Ophthalmic Technologies, Inc. Pipeline Products by Clinical Trials 86
Table 107: VisionCare Ophthalmic Technologies, Inc. Pipeline Products by
News Summaries 86
Table 108: Visual Pathways, Inc. Pipeline Products
by Equipment Type 87
Table 109: Visual Pathways, Inc. Pipeline
Products by Development Stage 87
Table 110: Visual Pathways, Inc.
Pipeline Products by Therapy Area 88
Table 111: Visual Pathways, Inc.
Pipeline Products by Clinical Trials 88
Table 112: Visual Pathways,
Inc. Pipeline Products by News Summaries 88
Table 113: Unilens Vision
Acquires Aero Contact Lens 89
Table 114: NovaMed Acquires Majority
Interest In Physicians Surgical Center 90
Table 115: Ken Martin And
Tom Olson Acquire Jims Optical 91
Table 116: OccuLogix Acquires
OcuSense 92
Table 117: Marchon Renews Its Agreement With Fendi 93
Table 118: Currency Conversion from USD to Local Currency at 2007 Constant
Rate 102
1.2 List of Figures
Figure 1: Ophthalmic Devices,
North America, Cross Country Comparison, Revenues ($ mn), 2000-2012 17
Figure 2: Ophthalmic Devices, North America, Overall Revenues ($ mn),
2000-2012 18
Figure 3: Ophthalmic Devices, North America, Portfolio
Analysis, 2000-2012 19
Figure 4: Ophthalmic Devices, North America,
Overall Revenues ($ mn), Historic, 2000-2007 20
Figure 5: Ophthalmic
Devices, North America, Overall Revenues ($ mn), Forecast, 2007-2012 21
Figure 6: Ophthalmic Devices, North America, Company Share (%), 2007
22
Figure 7: Ophthalmic Devices, United States, Overall Revenues ($
mn), 2000-2012 23
Figure 8: Ophthalmic Devices, United States,
Overall Revenues ($ mn), Historic, 2000-2007 24
Figure 9: Ophthalmic
Devices, United States, Overall Revenues ($ mn), Forecast, 2007-2012 25
Figure 10: Ophthalmic Devices, United States, Company Share (%), 2007
29
Figure 11: Cataract Surgery, United States, Company Share (%),
2007 30
Figure 12: Refractive Surgery, United States, Company Share
(%), 2007 31
Figure 13: Vision Care, United States, Company Share
(%), 2007 32
Figure 14: Ophthalmic Devices, Canada, Overall Revenues
($ mn), 2000-2012 33
Figure 15: Ophthalmic Devices, Canada, Overall
Revenues ($ mn), Historic, 2000-2007 34
Figure 16: Ophthalmic
Devices, Canada, Overall Revenues ($ mn), Forecast, 2007-2012 35
Figure
17: Ophthalmic Devices, Canada Company Share (%), 2007 39
Figure 18:
Cataract Surgery, Canada, Company Share (%), 2007 40
Figure 19:
Refractive Surgery, Canada, Company Share (%), 2007 41
Figure 20:
Vision Care, Canada, Company Share (%), 2007 42
Figure 21: Essilor
International Value Chain Analysis 44
Figure 22: Bausch & Lomb
Incorporated Value Chain Analysis 46
Figure 23: Alcon, Inc. Value
Chain Analysis 51
Figure 24: Advanced Medical Optics, Inc. Value
Chain Analysis 57
Figure 25: Carl Zeiss AG Value Chain Analysis
60
Figure 26: Global Markets Direct Methodology 98
|
Related Report
|
View Cart
